Early Clinical Development, Pfizer Worldwide R&D, Cambridge, MA, USA
Biography
Shanrong Zhao Early Clinical Development, Pfizer Worldwide R&D, Cambridge, MA, USA The ‘Union-exon’ based approach is simple, but it does not distinguish between isoforms when multiple alternatively spliced transcripts are expressed from the same gene. Because a gene is expressed in one or more transcript isoforms
